TherapeuticsMD (TXMD) Total Debt (2010 - 2022)

TherapeuticsMD (TXMD) has reported Total Debt for 9 consecutive years, with $95.4 million the latest figure, recorded in Q3 2022.

• For the quarter ending Q3 2022, Total Debt fell 48.94% year-over-year to $95.4 million; the trailing twelve-month figure through Sep 2022 stood at $95.4 million (down 48.94% YoY), and the FY2021 full-year result was $188.3 million, down 20.79% from the prior year.
• Total Debt advanced to $95.4 million in Q3 2022 per TXMD's latest filing, from $90.8 million in the prior quarter.
• Across five years, Total Debt topped out at $243.8 million in Q2 2020 and bottomed at $73.1 million in Q2 2018.
• Historically, Total Debt has averaged $165.4 million across 5 years, with a median of $188.6 million in 2021.
• The sharpest annual moves came in 2020 and 2022: Total Debt surged 231.19% in 2020, then sank 51.0% in 2022.
• Over 5 years, Total Debt stood at $73.4 million in 2018, then surged by 165.24% to $194.6 million in 2019, then rose by 22.13% to $237.7 million in 2020, then retreated by 20.79% to $188.3 million in 2021, then slumped by 49.35% to $95.4 million in 2022.
• According to Business Quant data, Total Debt over the past three periods registered $95.4 million, $90.8 million, and $202.9 million for Q3 2022, Q2 2022, and Q1 2022 respectively.